Based on low to very low certainty evidence, psychotropic-targeting deprescribing interventions may reduce falls in inpatient settings and in high-fidelity community programs, whereas effects were not clearly demonstrated in other settings. These findings support its potential role as a targeted strategy and underscore the need for high-fidelity protocols and adequately powered trials tailored to specific care settings.
Yin et al. (Tue,) studied this question.